✉ Email this page to a colleague
« Back to Dashboard
Poloxamer 407 is an investigational drug.
There have been 4 clinical trials for Poloxamer 407. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2011.
The most common disease conditions in clinical trials are Mucositis, Stomatitis, and Periodontitis. The leading clinical trial sponsors are University of Iowa, Ahmed Mohamed Mahrous, and Maha Talaab.
Recent Clinical Trials for Poloxamer 407
|Nitazoxanide as a New Local Adjunctive to Nonsurgical Treatment of Moderate Periodontitis||Maha Talaab||Phase 2|
|Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis||American College of Prosthodontists Education Foundation||Phase 2|
|Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis||Greater New York Academy of Prosthodontics||Phase 2|